Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra‐appendicular origin. BJS 2018; 105: 668-676.
Published: 7th February 2018
Authors: J.‐B. Delhorme, F. Severac, G. Averous, O. Glehen, G. Passot, N. Bakrin et al.
The prognostic value of the primary neoplasm responsible for pseudomyxoma peritonei (PMP) remains poorly studied. The aim of this study was to determine the prognosis for patients with extra‐appendicular PMP (EA‐PMP) treated optimally with complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
All patients treated for PMP with CCRS and HIPEC between 1994 and 2016 were selected retrospectively from a French multicentre database. Patients with EA‐PMP had pathologically confirmed non‐neoplastic appendices and were matched in a 1 : 4 ratio with patients treated for appendicular PMP (A‐PMP), based on a propensity score.
Some 726 patients were identified, of which 61 (EA‐PMP group) were matched with 244 patients (A‐PMP group). The origins of primary tumours in the EA‐PMP group included the ovary (45 patients), colon (4), urachus (4), small bowel (1), pancreas (1) and unknown (6). The median peritoneal carcinomatosis index was comparable in EA‐PMP and A‐PMP groups (15·5
Overall and disease‐free survival following treatment with CCRS and HIPEC is similar in patients with pseudomyxoma peritonei of appendicular or extra‐appendicular origin.Full text
You may also be interested in
Authors: R. Miller, J. C. R. Wormald, R. G. Wade, D. P. Collins
Time to calcitonin normalization after surgery for node‐negative and node‐positive medullary thyroid cancer.
Authors: A. Machens, K. Lorenz, H. Dralle
Notes: Sensitive as prognostic tool
Contralateral surgery in patients scheduled for total thyroidectomy with initial loss or absence of signal during neural monitoring.
Authors: A. Sitges‐Serra, L. Gallego‐Otaegui, J. Fontané, L. Trillo, L. Lorente‐Poch, J. Sancho et al.
Authors: L. M. Almond, F. Tirotta, H. Tattersall, J. Hodson, T. Cascella, M. Barisella et al.
Notes: Weak for liposarcoma
Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death. BJS 2019; 106: 174-180.
Authors: I. M. Shapey, A. Summers, T. Augustine, D. van Dellen
Authors: K. R. Iverson, K. Garringer, O. Ahearn, S. Alidina, I. Citron, S. Esseye et al.
Notes: Much to be done still
Evaluation of a surgical training programme for clinical officers in Malawi. BJS 2019; 106: e156-e165.
Authors: J. Gajewski, E. Borgstein, L. Bijlmakers, G. Mwapasa, Z. Aljohani, C. Pittalis et al.
Implementation and evaluation of nationwide scale‐up of the Surgical Safety Checklist. BJS 2019; 106: e91-e102.
Authors: M. C. White, K. Randall, N. F. E. Capo‐Chichi, F. Sodogas, S. Quenum, K. Wright et al.
Notes: Implementation works
Authors: B. L. Hedt‐Gauthier, R. Riviello, T. Nkurunziza, F. Kateera
Authors: W. S. Bolton, N. Aruparayil, A. Quyn, J. Scott, A. Wood, I. Bundu et al.
Notes: How to do it
A realized vision of access to safe, affordable surgical and anaesthesia care. BJS 2019; 106: e24-e26.
Authors: L. Hagander, A. Leather